Rapid and effective malaria control in Cambodia through mass administration of artemisinin-piperaquine View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2010-02-23

AUTHORS

Jianping Song, Duong Socheat, Bo Tan, Prak Dara, Changsheng Deng, Sreng Sokunthea, Suon Seila, Fengzhen Ou, Huaxiang Jian, Guoqiao Li

ABSTRACT

BACKGROUND: Previous efforts to eradicate malaria parasites, particularly Plasmodium falciparum, have failed in part due to the emergence of drug resistant parasites and mosquitoes resistant to insecticides. Using an artemisinin-based combination therapy (ACT) that kills parasites quickly, a strategy was designed to eliminate the source of transmission by mass treatment of human populations in malaria-endemic areas Cambodia. METHODS: A combination drug of artemisinin and piperaquine given with low doses of primaquine was used to eliminate all stages of parasites from human carriers. RESULTS: In a pilot study, mass administration of artemisinin-piperaquine (two tablets of 62.5 mg artemisinin and 375 mg piperaquine for adults aged > or =16 years at 0 and 24 hrs; 1.5 tablet for children aged 11-15 years; and one tablet for children aged 6-10 years) and primaquine (9 mg for adults, at 10 day intervals for 6 months) was carried out in 17 villages (3,653 individuals). Parasite rates were dramatically reduced from 52.3% to 2.6% after three years. The P. falciparum rate in children decreased from 37.0% to 1.4%, reaching 0% in eight of 17 villages. In a second field study, that included one additional mass treatment of artemisinin-piperaquine, the P. falciparum rate in children was reduced from 20.8% to 0% within six months. No major adverse effects were observed. CONCLUSIONS: Mass administration of artemisinin-piperaquine and low doses of primaquine can be an effective, safe, and affordable strategy for efficiently eliminating malaria parasites in human carriers and interrupting parasite transmission. This study provides important information for future strategies for the eradication of malaria. More... »

PAGES

57-57

Identifiers

URI

http://scigraph.springernature.com/pub.10.1186/1475-2875-9-57

DOI

http://dx.doi.org/10.1186/1475-2875-9-57

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1024339848

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/20175930


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1108", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical Microbiology", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1117", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Public Health and Health Services", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Administration, Oral", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adolescent", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Anti-Infective Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antimalarials", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Artemisinins", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cambodia", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Child", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Administration Schedule", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Therapy, Combination", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Endemic Diseases", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Malaria, Falciparum", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Parasitemia", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Pilot Projects", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Plasmodium falciparum", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Population Surveillance", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Primaquine", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Quinolines", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Treatment Outcome", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Research Centre for Qinghao, Guangzhou University of Chinese Medicine, Guangzhou, PR China", 
          "id": "http://www.grid.ac/institutes/grid.411866.c", 
          "name": [
            "Research Centre for Qinghao, Guangzhou University of Chinese Medicine, Guangzhou, PR China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Song", 
        "givenName": "Jianping", 
        "id": "sg:person.01223607653.18", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01223607653.18"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "National Centre for Parasitology, Entomology and Malaria Control, Phnom Penh, Cambodia", 
          "id": "http://www.grid.ac/institutes/grid.452707.3", 
          "name": [
            "National Centre for Parasitology, Entomology and Malaria Control, Phnom Penh, Cambodia"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Socheat", 
        "givenName": "Duong", 
        "id": "sg:person.01052444622.71", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01052444622.71"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Research Centre for Qinghao, Guangzhou University of Chinese Medicine, Guangzhou, PR China", 
          "id": "http://www.grid.ac/institutes/grid.411866.c", 
          "name": [
            "Research Centre for Qinghao, Guangzhou University of Chinese Medicine, Guangzhou, PR China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Tan", 
        "givenName": "Bo", 
        "id": "sg:person.01340036253.56", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01340036253.56"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Health, Kampong Speu, Cambodia", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Department of Health, Kampong Speu, Cambodia"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Dara", 
        "givenName": "Prak", 
        "id": "sg:person.01023657641.00", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01023657641.00"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Research Centre for Qinghao, Guangzhou University of Chinese Medicine, Guangzhou, PR China", 
          "id": "http://www.grid.ac/institutes/grid.411866.c", 
          "name": [
            "Research Centre for Qinghao, Guangzhou University of Chinese Medicine, Guangzhou, PR China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Deng", 
        "givenName": "Changsheng", 
        "id": "sg:person.0662545353.18", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0662545353.18"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "National Centre for Parasitology, Entomology and Malaria Control, Phnom Penh, Cambodia", 
          "id": "http://www.grid.ac/institutes/grid.452707.3", 
          "name": [
            "National Centre for Parasitology, Entomology and Malaria Control, Phnom Penh, Cambodia"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Sokunthea", 
        "givenName": "Sreng", 
        "id": "sg:person.01154535223.35", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01154535223.35"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "National Centre for Parasitology, Entomology and Malaria Control, Phnom Penh, Cambodia", 
          "id": "http://www.grid.ac/institutes/grid.452707.3", 
          "name": [
            "National Centre for Parasitology, Entomology and Malaria Control, Phnom Penh, Cambodia"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Seila", 
        "givenName": "Suon", 
        "id": "sg:person.01106422023.26", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01106422023.26"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Research Centre for Qinghao, Guangzhou University of Chinese Medicine, Guangzhou, PR China", 
          "id": "http://www.grid.ac/institutes/grid.411866.c", 
          "name": [
            "Research Centre for Qinghao, Guangzhou University of Chinese Medicine, Guangzhou, PR China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ou", 
        "givenName": "Fengzhen", 
        "id": "sg:person.01045107153.92", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01045107153.92"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Research Centre for Qinghao, Guangzhou University of Chinese Medicine, Guangzhou, PR China", 
          "id": "http://www.grid.ac/institutes/grid.411866.c", 
          "name": [
            "Research Centre for Qinghao, Guangzhou University of Chinese Medicine, Guangzhou, PR China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Jian", 
        "givenName": "Huaxiang", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Research Centre for Qinghao, Guangzhou University of Chinese Medicine, Guangzhou, PR China", 
          "id": "http://www.grid.ac/institutes/grid.411866.c", 
          "name": [
            "Research Centre for Qinghao, Guangzhou University of Chinese Medicine, Guangzhou, PR China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Li", 
        "givenName": "Guoqiao", 
        "id": "sg:person.01071773041.98", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01071773041.98"
        ], 
        "type": "Person"
      }
    ], 
    "datePublished": "2010-02-23", 
    "datePublishedReg": "2010-02-23", 
    "description": "BACKGROUND: Previous efforts to eradicate malaria parasites, particularly Plasmodium falciparum, have failed in part due to the emergence of drug resistant parasites and mosquitoes resistant to insecticides. Using an artemisinin-based combination therapy (ACT) that kills parasites quickly, a strategy was designed to eliminate the source of transmission by mass treatment of human populations in malaria-endemic areas Cambodia.\nMETHODS: A combination drug of artemisinin and piperaquine given with low doses of primaquine was used to eliminate all stages of parasites from human carriers.\nRESULTS: In a pilot study, mass administration of artemisinin-piperaquine (two tablets of 62.5 mg artemisinin and 375 mg piperaquine for adults aged > or =16 years at 0 and 24 hrs; 1.5 tablet for children aged 11-15 years; and one tablet for children aged 6-10 years) and primaquine (9 mg for adults, at 10 day intervals for 6 months) was carried out in 17 villages (3,653 individuals). Parasite rates were dramatically reduced from 52.3% to 2.6% after three years. The P. falciparum rate in children decreased from 37.0% to 1.4%, reaching 0% in eight of 17 villages. In a second field study, that included one additional mass treatment of artemisinin-piperaquine, the P. falciparum rate in children was reduced from 20.8% to 0% within six months. No major adverse effects were observed.\nCONCLUSIONS: Mass administration of artemisinin-piperaquine and low doses of primaquine can be an effective, safe, and affordable strategy for efficiently eliminating malaria parasites in human carriers and interrupting parasite transmission. This study provides important information for future strategies for the eradication of malaria.", 
    "genre": "article", 
    "id": "sg:pub.10.1186/1475-2875-9-57", 
    "inLanguage": "en", 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1030597", 
        "issn": [
          "1475-2875"
        ], 
        "name": "Malaria Journal", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "9"
      }
    ], 
    "keywords": [
      "artemisinin-based combination therapy", 
      "mass administration", 
      "falciparum rate", 
      "mass treatment", 
      "low doses", 
      "human carriers", 
      "malaria parasites", 
      "major adverse effects", 
      "drug-resistant parasites", 
      "source of transmission", 
      "eradication of malaria", 
      "effective malaria control", 
      "combination therapy", 
      "parasite rate", 
      "combination drugs", 
      "resistant parasites", 
      "malaria control", 
      "stage of parasite", 
      "Plasmodium falciparum", 
      "pilot study", 
      "adverse effects", 
      "administration", 
      "primaquine", 
      "doses", 
      "parasite transmission", 
      "future strategies", 
      "parasites", 
      "treatment", 
      "children", 
      "affordable strategy", 
      "piperaquine", 
      "therapy", 
      "malaria", 
      "human populations", 
      "study", 
      "months", 
      "falciparum", 
      "drugs", 
      "eradication", 
      "rate", 
      "artemisinin", 
      "important information", 
      "mosquitoes", 
      "transmission", 
      "population", 
      "years", 
      "strategies", 
      "carriers", 
      "Cambodia", 
      "control", 
      "effect", 
      "stage", 
      "villages", 
      "second field study", 
      "insecticides", 
      "efforts", 
      "part", 
      "information", 
      "emergence", 
      "previous efforts", 
      "source", 
      "field study", 
      "malaria-endemic areas Cambodia", 
      "areas Cambodia", 
      "additional mass treatment"
    ], 
    "name": "Rapid and effective malaria control in Cambodia through mass administration of artemisinin-piperaquine", 
    "pagination": "57-57", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1024339848"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1186/1475-2875-9-57"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "20175930"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1186/1475-2875-9-57", 
      "https://app.dimensions.ai/details/publication/pub.1024339848"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2021-12-01T19:23", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20211201/entities/gbq_results/article/article_518.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1186/1475-2875-9-57"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/1475-2875-9-57'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/1475-2875-9-57'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/1475-2875-9-57'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/1475-2875-9-57'


 

This table displays all metadata directly associated to this object as RDF triples.

290 TRIPLES      21 PREDICATES      115 URIs      105 LITERALS      29 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1186/1475-2875-9-57 schema:about N18ffcca72bfa48e9bbb3295914231c05
2 N381aeac192e6469a8e78bcf0ea67e21f
3 N389b355c051841438c1cc80317bcfdce
4 N46d553ef1b5a4666aaf032d0e4d476ac
5 N4704f967219c418c9f25c93664a75336
6 N53b31e5ca306484e8763669cf80bcc51
7 N5cd55532ee674ad1a3694a4f290cfb51
8 N673df3e9996140eb9946196dcb634561
9 N7939cb62f78547eb9c9fae3c61522bf9
10 N79966c475e6f4959b4b44f2aafcb0def
11 N7e4542b969b940f6a67d34ccfc04fcd3
12 N7f48b8c58bd84658a0fbdd565be19896
13 N809d23aa1c664f5a8836d662338c133d
14 N81c1831506814c0d9dca2fe1e47e8eff
15 N9326639ee85b40f1bd5e498e03f5bedb
16 Na557f737249a46a19538584cf6315da4
17 Nb607b70404254e599f655d9f7d5b80af
18 Nb8de2a085f7545399d9a19ec4bb8be89
19 Nca204bf52b124a35a148685fee448baf
20 Nca834c83cd2d41c0b1c2e1135d6cf6fe
21 Ne5c1ddb348a84cd3bd818c31364340c6
22 Nef6d8051836c44c597ad62007edcfed2
23 anzsrc-for:11
24 anzsrc-for:1103
25 anzsrc-for:1108
26 anzsrc-for:1117
27 schema:author N215b92c1fff145ac80e18f318466375e
28 schema:datePublished 2010-02-23
29 schema:datePublishedReg 2010-02-23
30 schema:description BACKGROUND: Previous efforts to eradicate malaria parasites, particularly Plasmodium falciparum, have failed in part due to the emergence of drug resistant parasites and mosquitoes resistant to insecticides. Using an artemisinin-based combination therapy (ACT) that kills parasites quickly, a strategy was designed to eliminate the source of transmission by mass treatment of human populations in malaria-endemic areas Cambodia. METHODS: A combination drug of artemisinin and piperaquine given with low doses of primaquine was used to eliminate all stages of parasites from human carriers. RESULTS: In a pilot study, mass administration of artemisinin-piperaquine (two tablets of 62.5 mg artemisinin and 375 mg piperaquine for adults aged > or =16 years at 0 and 24 hrs; 1.5 tablet for children aged 11-15 years; and one tablet for children aged 6-10 years) and primaquine (9 mg for adults, at 10 day intervals for 6 months) was carried out in 17 villages (3,653 individuals). Parasite rates were dramatically reduced from 52.3% to 2.6% after three years. The P. falciparum rate in children decreased from 37.0% to 1.4%, reaching 0% in eight of 17 villages. In a second field study, that included one additional mass treatment of artemisinin-piperaquine, the P. falciparum rate in children was reduced from 20.8% to 0% within six months. No major adverse effects were observed. CONCLUSIONS: Mass administration of artemisinin-piperaquine and low doses of primaquine can be an effective, safe, and affordable strategy for efficiently eliminating malaria parasites in human carriers and interrupting parasite transmission. This study provides important information for future strategies for the eradication of malaria.
31 schema:genre article
32 schema:inLanguage en
33 schema:isAccessibleForFree true
34 schema:isPartOf N40565e1390af42108e6dc231607f6ead
35 Nf9db19929e08459c80dd33ddd247674d
36 sg:journal.1030597
37 schema:keywords Cambodia
38 Plasmodium falciparum
39 additional mass treatment
40 administration
41 adverse effects
42 affordable strategy
43 areas Cambodia
44 artemisinin
45 artemisinin-based combination therapy
46 carriers
47 children
48 combination drugs
49 combination therapy
50 control
51 doses
52 drug-resistant parasites
53 drugs
54 effect
55 effective malaria control
56 efforts
57 emergence
58 eradication
59 eradication of malaria
60 falciparum
61 falciparum rate
62 field study
63 future strategies
64 human carriers
65 human populations
66 important information
67 information
68 insecticides
69 low doses
70 major adverse effects
71 malaria
72 malaria control
73 malaria parasites
74 malaria-endemic areas Cambodia
75 mass administration
76 mass treatment
77 months
78 mosquitoes
79 parasite rate
80 parasite transmission
81 parasites
82 part
83 pilot study
84 piperaquine
85 population
86 previous efforts
87 primaquine
88 rate
89 resistant parasites
90 second field study
91 source
92 source of transmission
93 stage
94 stage of parasite
95 strategies
96 study
97 therapy
98 transmission
99 treatment
100 villages
101 years
102 schema:name Rapid and effective malaria control in Cambodia through mass administration of artemisinin-piperaquine
103 schema:pagination 57-57
104 schema:productId N1a7f3e86055e4b97b6290d80f7862326
105 N27e01b3abb154ca8903373442b2a3081
106 Nd463ec9b336c490ebaa0df160afb9490
107 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024339848
108 https://doi.org/10.1186/1475-2875-9-57
109 schema:sdDatePublished 2021-12-01T19:23
110 schema:sdLicense https://scigraph.springernature.com/explorer/license/
111 schema:sdPublisher Nfcdb032f0a4147a49123cd27d0c26e22
112 schema:url https://doi.org/10.1186/1475-2875-9-57
113 sgo:license sg:explorer/license/
114 sgo:sdDataset articles
115 rdf:type schema:ScholarlyArticle
116 N18ffcca72bfa48e9bbb3295914231c05 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
117 schema:name Malaria, Falciparum
118 rdf:type schema:DefinedTerm
119 N1a7f3e86055e4b97b6290d80f7862326 schema:name pubmed_id
120 schema:value 20175930
121 rdf:type schema:PropertyValue
122 N1e3ade746d4841fb8a31d5c37dfbedc6 rdf:first sg:person.01071773041.98
123 rdf:rest rdf:nil
124 N215b92c1fff145ac80e18f318466375e rdf:first sg:person.01223607653.18
125 rdf:rest N8fff3a0e3a88461682c170d9c5680019
126 N27e01b3abb154ca8903373442b2a3081 schema:name dimensions_id
127 schema:value pub.1024339848
128 rdf:type schema:PropertyValue
129 N381aeac192e6469a8e78bcf0ea67e21f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
130 schema:name Population Surveillance
131 rdf:type schema:DefinedTerm
132 N389b355c051841438c1cc80317bcfdce schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
133 schema:name Female
134 rdf:type schema:DefinedTerm
135 N39f0bf68f22740eaaa30a44d398b727e rdf:first sg:person.01340036253.56
136 rdf:rest Nf59161cd714b433d8819e5697fafefd5
137 N40565e1390af42108e6dc231607f6ead schema:volumeNumber 9
138 rdf:type schema:PublicationVolume
139 N46d553ef1b5a4666aaf032d0e4d476ac schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
140 schema:name Quinolines
141 rdf:type schema:DefinedTerm
142 N4704f967219c418c9f25c93664a75336 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
143 schema:name Treatment Outcome
144 rdf:type schema:DefinedTerm
145 N53b31e5ca306484e8763669cf80bcc51 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
146 schema:name Primaquine
147 rdf:type schema:DefinedTerm
148 N5cd55532ee674ad1a3694a4f290cfb51 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
149 schema:name Artemisinins
150 rdf:type schema:DefinedTerm
151 N673df3e9996140eb9946196dcb634561 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
152 schema:name Parasitemia
153 rdf:type schema:DefinedTerm
154 N67b8248649c64e2d8800bc97a32f9760 rdf:first sg:person.01045107153.92
155 rdf:rest N686d5d470cd146159b71c8014746e5e2
156 N686d5d470cd146159b71c8014746e5e2 rdf:first Nf38228bf964d4be3a84c286674fc009d
157 rdf:rest N1e3ade746d4841fb8a31d5c37dfbedc6
158 N6d59ce5408274406b8fa0231d8ae6f69 rdf:first sg:person.01154535223.35
159 rdf:rest Na47f3740817d4b33a16272075524862b
160 N7939cb62f78547eb9c9fae3c61522bf9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
161 schema:name Pilot Projects
162 rdf:type schema:DefinedTerm
163 N79966c475e6f4959b4b44f2aafcb0def schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
164 schema:name Adolescent
165 rdf:type schema:DefinedTerm
166 N7e4542b969b940f6a67d34ccfc04fcd3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
167 schema:name Cambodia
168 rdf:type schema:DefinedTerm
169 N7f48b8c58bd84658a0fbdd565be19896 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
170 schema:name Drug Administration Schedule
171 rdf:type schema:DefinedTerm
172 N809d23aa1c664f5a8836d662338c133d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
173 schema:name Adult
174 rdf:type schema:DefinedTerm
175 N81c1831506814c0d9dca2fe1e47e8eff schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
176 schema:name Administration, Oral
177 rdf:type schema:DefinedTerm
178 N8fff3a0e3a88461682c170d9c5680019 rdf:first sg:person.01052444622.71
179 rdf:rest N39f0bf68f22740eaaa30a44d398b727e
180 N91e549c2d45b4ee79224b4733d349ed2 rdf:first sg:person.0662545353.18
181 rdf:rest N6d59ce5408274406b8fa0231d8ae6f69
182 N9326639ee85b40f1bd5e498e03f5bedb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
183 schema:name Male
184 rdf:type schema:DefinedTerm
185 Na47f3740817d4b33a16272075524862b rdf:first sg:person.01106422023.26
186 rdf:rest N67b8248649c64e2d8800bc97a32f9760
187 Na557f737249a46a19538584cf6315da4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
188 schema:name Anti-Infective Agents
189 rdf:type schema:DefinedTerm
190 Nb607b70404254e599f655d9f7d5b80af schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
191 schema:name Drug Therapy, Combination
192 rdf:type schema:DefinedTerm
193 Nb8de2a085f7545399d9a19ec4bb8be89 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
194 schema:name Humans
195 rdf:type schema:DefinedTerm
196 Nca204bf52b124a35a148685fee448baf schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
197 schema:name Antimalarials
198 rdf:type schema:DefinedTerm
199 Nca834c83cd2d41c0b1c2e1135d6cf6fe schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
200 schema:name Plasmodium falciparum
201 rdf:type schema:DefinedTerm
202 Nd463ec9b336c490ebaa0df160afb9490 schema:name doi
203 schema:value 10.1186/1475-2875-9-57
204 rdf:type schema:PropertyValue
205 Ne5c1ddb348a84cd3bd818c31364340c6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
206 schema:name Child
207 rdf:type schema:DefinedTerm
208 Nef6d8051836c44c597ad62007edcfed2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
209 schema:name Endemic Diseases
210 rdf:type schema:DefinedTerm
211 Nf38228bf964d4be3a84c286674fc009d schema:affiliation grid-institutes:grid.411866.c
212 schema:familyName Jian
213 schema:givenName Huaxiang
214 rdf:type schema:Person
215 Nf59161cd714b433d8819e5697fafefd5 rdf:first sg:person.01023657641.00
216 rdf:rest N91e549c2d45b4ee79224b4733d349ed2
217 Nf9db19929e08459c80dd33ddd247674d schema:issueNumber 1
218 rdf:type schema:PublicationIssue
219 Nfcdb032f0a4147a49123cd27d0c26e22 schema:name Springer Nature - SN SciGraph project
220 rdf:type schema:Organization
221 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
222 schema:name Medical and Health Sciences
223 rdf:type schema:DefinedTerm
224 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
225 schema:name Clinical Sciences
226 rdf:type schema:DefinedTerm
227 anzsrc-for:1108 schema:inDefinedTermSet anzsrc-for:
228 schema:name Medical Microbiology
229 rdf:type schema:DefinedTerm
230 anzsrc-for:1117 schema:inDefinedTermSet anzsrc-for:
231 schema:name Public Health and Health Services
232 rdf:type schema:DefinedTerm
233 sg:journal.1030597 schema:issn 1475-2875
234 schema:name Malaria Journal
235 schema:publisher Springer Nature
236 rdf:type schema:Periodical
237 sg:person.01023657641.00 schema:affiliation grid-institutes:None
238 schema:familyName Dara
239 schema:givenName Prak
240 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01023657641.00
241 rdf:type schema:Person
242 sg:person.01045107153.92 schema:affiliation grid-institutes:grid.411866.c
243 schema:familyName Ou
244 schema:givenName Fengzhen
245 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01045107153.92
246 rdf:type schema:Person
247 sg:person.01052444622.71 schema:affiliation grid-institutes:grid.452707.3
248 schema:familyName Socheat
249 schema:givenName Duong
250 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01052444622.71
251 rdf:type schema:Person
252 sg:person.01071773041.98 schema:affiliation grid-institutes:grid.411866.c
253 schema:familyName Li
254 schema:givenName Guoqiao
255 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01071773041.98
256 rdf:type schema:Person
257 sg:person.01106422023.26 schema:affiliation grid-institutes:grid.452707.3
258 schema:familyName Seila
259 schema:givenName Suon
260 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01106422023.26
261 rdf:type schema:Person
262 sg:person.01154535223.35 schema:affiliation grid-institutes:grid.452707.3
263 schema:familyName Sokunthea
264 schema:givenName Sreng
265 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01154535223.35
266 rdf:type schema:Person
267 sg:person.01223607653.18 schema:affiliation grid-institutes:grid.411866.c
268 schema:familyName Song
269 schema:givenName Jianping
270 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01223607653.18
271 rdf:type schema:Person
272 sg:person.01340036253.56 schema:affiliation grid-institutes:grid.411866.c
273 schema:familyName Tan
274 schema:givenName Bo
275 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01340036253.56
276 rdf:type schema:Person
277 sg:person.0662545353.18 schema:affiliation grid-institutes:grid.411866.c
278 schema:familyName Deng
279 schema:givenName Changsheng
280 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0662545353.18
281 rdf:type schema:Person
282 grid-institutes:None schema:alternateName Department of Health, Kampong Speu, Cambodia
283 schema:name Department of Health, Kampong Speu, Cambodia
284 rdf:type schema:Organization
285 grid-institutes:grid.411866.c schema:alternateName Research Centre for Qinghao, Guangzhou University of Chinese Medicine, Guangzhou, PR China
286 schema:name Research Centre for Qinghao, Guangzhou University of Chinese Medicine, Guangzhou, PR China
287 rdf:type schema:Organization
288 grid-institutes:grid.452707.3 schema:alternateName National Centre for Parasitology, Entomology and Malaria Control, Phnom Penh, Cambodia
289 schema:name National Centre for Parasitology, Entomology and Malaria Control, Phnom Penh, Cambodia
290 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...